PeptidePedia The community reference

WuXi TIDES: difference between revisions

Diff·revision 12 → 13·04:40, 20 Nov 2024

Difference between revision 12 and revision 13 of WuXi TIDES. 9 lines changed; the page grew by 1,195 bytes.

Revision 12 — 05:50, 6 Nov 2024
ReportReaderRilla (talk)
convert a hard-coded date to the house format
5,922 bytes ±0
Revision 13 — 04:40, 20 Nov 2024
SecondarySrc_Seb (talk)
add the incorporation year, attributed to the registry record
7,117 bytes +1,195
1{{Infobox organisation1{{Infobox organisation
2| name = WuXi TIDES (WuXi AppTec Testing Division)2| name = WuXi TIDES (WuXi AppTec Testing Division)
+3| subtitle = Organisation
3| image = facility.svg4| image = facility.svg
4| caption = Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki.5| caption = Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki.
12| Official site = [https://wuxitides.net/ Visit WXT at wuxitides.net]13| Official site = [https://wuxitides.net/ Visit WXT at wuxitides.net]
13}}14}}
+15{{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}}
1416
15'''WuXi TIDES (WuXi AppTec Testing Division)''' (trading as '''WXT'''; wuxitides.net) is a research-compound supplier trading as WXT from Wuxi, Jiangsu, China, incorporated in 2002 and distributing peptides, oligonucleotides and related research materials with batch documentation and tracked international shipping.{{r|registry,selfpub}}17'''WuXi TIDES (WuXi AppTec Testing Division)''' (trading as '''WXT'''; wuxitides.net) is a research-compound supplier trading as WXT from Wuxi, Jiangsu, China, incorporated in 2002 and distributing peptides, oligonucleotides and related research materials with batch documentation and tracked international shipping.{{r|registry,selfpub}}
30Documentation practice is the most consistently described aspect of the organisation in reports reaching this wiki: shipments are reported to arrive with a batch-specific [[Certificate of analysis|certificate]] naming a [[Batch number|lot]], and the lot identifier on the certificate has matched the vial label throughout the submitted material.{{r|reports}} That correspondence is the condition every other document depends on, and it is recorded here because it is the one thing a purchaser can verify on arrival without instrumentation.32Documentation practice is the most consistently described aspect of the organisation in reports reaching this wiki: shipments are reported to arrive with a batch-specific [[Certificate of analysis|certificate]] naming a [[Batch number|lot]], and the lot identifier on the certificate has matched the vial label throughout the submitted material.{{r|reports}} That correspondence is the condition every other document depends on, and it is recorded here because it is the one thing a purchaser can verify on arrival without instrumentation.
3133
+34Nothing in the public record establishes the physical arrangement of manufacturing, whether synthesis is performed in-house or contracted, or what quality system governs it. Statements about staff numbers, floor area or certification in the organisation's own material are self-published and are not corroborated here.{{r|selfpub}}
+35
32== Product range ==36== Product range ==
33| Class | Representative listings | Documentation reported |37| Class | Representative listings | Documentation reported |
37| Oligonucleotides | Custom synthesis, antisense constructs | Certificate, sequence confirmation |41| Oligonucleotides | Custom synthesis, antisense constructs | Certificate, sequence confirmation |
38| SARMs and raw materials | Bulk powders | Certificate with purity; specification sheet on request |42| SARMs and raw materials | Bulk powders | Certificate with purity; specification sheet on request |
+43
+44The oligonucleotide listings distinguish this organisation from most others covered here, whose catalogues are peptide-only. Whether that reflects in-house capability or brokerage is not established by any source available to this wiki.{{r|selfpub}}
+45
+46== Independent testing record ==
+47Reports on WXT material submitted to PeptidePedia between 2024 and 2026 cover the incretin analogues most heavily, with a smaller number on research peptides. Where a report and the accompanying certificate can be compared, reported [[Area percent purity|area percent]] figures have generally agreed within a few tenths of a percent.{{r|reports}}
3948
40== References ==49== References ==